Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus.

被引：0
作者：
Petrik, G. G. [1 ]
Pavlishchuk, S. A. [1 ]
机构：
[1] Kuban State Med Univ, Krasnodar, Russia
来源：
CARDIOVASCULAR THERAPY AND PREVENTION | 2010年 / 9卷 / 02期
关键词：
INSULIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 53
页数：6
相关论文
共 50 条
[41]   Glucose-lowering drug use in migrants and native Danes with type 2 diabetes: Disparities in combination therapy and drug types [J].
Isaksen, Anders Aasted ;
Sandbaek, Annelli ;
Skriver, Mette Vinther ;
Bjerg, Lasse .
DIABETES OBESITY & METABOLISM, 2023, 25 (11) :3307-3316
[42]   Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy [J].
Noh, Yoojin ;
Jeon, Sang-Min ;
Shin, Sooyoung .
INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (07) :1530-1539
[43]   Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years? [J].
Bo Ahrén .
Diabetologia, 2015, 58 :1740-1744
[44]   Association between Glucose-lowering Treatments and Risk of Diabetic Retinopathy in People with Type 2 Diabetes: A Nationwide Cohort Study [J].
Jensen, Jakob Hasselstrom ;
Vestergaard, Peter ;
Jensen, Morten Hasselstrom .
CURRENT DRUG SAFETY, 2024, 19 (02) :236-243
[45]   Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment [J].
N. Saleh ;
P. Petursson ;
B. Lagerqvist ;
H. Skúladóttir ;
A. Svensson ;
B. Eliasson ;
S. Gudbjörnsdottir ;
K. Eeg-Olofsson ;
A. Norhammar .
Diabetologia, 2012, 55 :2109-2117
[46]   Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment [J].
Saleh, N. ;
Petursson, P. ;
Lagerqvist, B. ;
Skuladottir, H. ;
Svensson, A. ;
Eliasson, B. ;
Gudbjornsdottir, S. ;
Eeg-Olofsson, K. ;
Norhammar, A. .
DIABETOLOGIA, 2012, 55 (08) :2109-2117
[47]   Vitamin A levels are decreased but not influenced by glucose- or lipid-lowering medications in subjects with type 2 diabetes [J].
Taneera, Jalal ;
Awadallah, Samir ;
Mohammed, Abdul Khader ;
Unnikannan, Hema ;
Sulaiman, Nabil .
SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (01) :572-577
[48]   Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial [J].
Arnold, Suzanne V. ;
McGuire, Darren K. ;
Spertus, John A. ;
Tang, Fengming ;
Yue, Patrick ;
Inzucchi, Silvio E. ;
Belardinelli, Luiz ;
Chaitman, Bernard R. ;
Kosiborod, Mikhail .
AMERICAN HEART JOURNAL, 2015, 170 (04) :753-+
[49]   Postprandial glucose-lowering effects by sago (Metroxylon sagu Rottb.) resistant starch in spontaneously type 2 diabetes, Goto-Kakizaki rat [J].
Lokman, Ezarul Faradianna ;
Bugam, Sal Hazreen ;
Ibrahim, Aina Shafiza ;
Yunus, Nurleyna ;
Mansor, Fazliana ;
Balasubramaniam, Vimala ;
Mohamad, Khairul Mirza ;
Md Lazim, Rabizah ;
Awang Seruji, Awang Zulfikar Rizal .
NUTRITION AND HEALTH, 2025, 31 (01) :101-110
[50]   Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR) [J].
Arnold, Suzanne V. ;
Echouffo-Tcheugui, Justin B. ;
Lam, Carolyn S. P. ;
Inzucchi, Silvio E. ;
Tang, Fengming ;
McGuire, Darren K. ;
Goyal, Abhinav ;
Maddox, Thomas M. ;
Sperling, Laurence S. ;
Fonarow, Gregg C. ;
Masoudi, Frederick A. ;
Kosiborod, Mikhail .
AMERICAN HEART JOURNAL, 2018, 203 :25-29
12345